Stage
Loan | AliveTotal Raised
$3.08MLast Raised
$680K | 2 yrs agoAbout Kurin
Kurin develops blood culture collection technology focusing on the contaminants originating in the patient's own skin, which challenge hospital efforts to address false-positive blood cultures. Standing guard between the venipuncture site and the culture bottle, the Kurin Lock diverts the initial blood flow that may contain microbes from deep within the skin. A clinically-relevant blood sample then bypasses the contaminants locked within the device.
Kurin Headquarter Location
10755 Scripps Poway Parkway No. 257
San Diego, California, 92131,
United States
888-963-9056
Expert Collections containing Kurin
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
Kurin is included in 2 Expert Collections, including Medical Devices.
Medical Devices
11,167 items
Companies developing medical devices (per the IMDRF's definition of "medical device"). Includes software, lab-developed tests (LDTs), and combination products. *Columns updated as regularly as possible.
Health IT
7,900 items
Kurin Patents
Kurin has filed 15 patents.
The 3 most popular patent topics include:
- Blood tests
- Intensive care medicine
- Blood
Application Date | Grant Date | Title | Related Topics | Status |
|---|---|---|---|---|
12/27/2017 | 4/26/2022 | Blood tests, Blood, Intensive care medicine, Hematology, Medical equipment | Grant |
Application Date | 12/27/2017 |
|---|---|
Grant Date | 4/26/2022 |
Title | |
Related Topics | Blood tests, Blood, Intensive care medicine, Hematology, Medical equipment |
Status | Grant |
Latest Kurin News
Feb 23, 2022
February 23, 2022 06:00 AM Eastern Standard Time SAN DIEGO--( BUSINESS WIRE )--Kurin, Inc., the inventor and manufacturer of the Kurin® blood culture collection sets announced that they have commenced the commercial launch of their push-button needle, to be used as part of Kurin blood culture sets. The Advance Safety Needle System was tested in 2021 and is now being sold into accounts using Kurin. “We are proud to commercialize the Advance Safety Needle, as there has been market demand for alternatives and improvements in this space,” said Bob Rogers, CEO of Kurin, Inc. “We are pleased with our field trials performed over the past several months. In addition to the positive feedback that we received, our testing shows improved performance characteristics compared to traditional, retraction-oriented products. The development of the Advance Needle is an important milestone for Kurin, providing us a more reliable supply of product, better cost control, the opportunity to offer improved benefits over current needles, and creates new strategic opportunities in which we are already engaged.” Kurin’s revolutionary approach to the contaminated blood culture problem is an elegantly simple, intuitive design that requires no additional user steps. Kurin passively sidelines potential contaminants during blood culture collection. Kurin is a simply better and more sustainable approach over conventional mechanical diversion. Contaminated blood cultures are a significant problem, as roughly one-third of the positive results are wrong, exposing these patients to unnecessary antibiotics, extending hospital stays and impacting larger community health issues, such as antimicrobial resistance and the life-threatening C. diff. infection. About Kurin, Inc. Kurin, Inc., a certified Minority Business Enterprise (MBE), is focused on the design, development, manufacture, marketing, and sale of products that help healthcare providers reduce contaminated blood cultures. Kurin, manufactured in San Diego, CA, has received FDA 510(k) market clearance. For more information about Kurin, visit the website at www.kurin.com . Contacts
Kurin Web Traffic
Kurin Rank
Where is Kurin's headquarters?
Kurin's headquarters is located at 10755 Scripps Poway Parkway, San Diego.
What is Kurin's latest funding round?
Kurin's latest funding round is Loan.
How much did Kurin raise?
Kurin raised a total of $3.08M.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.